Biomems and Biomedical Nanotechnology: v. 2: Micro-and-nano-technologies for Genomics and Proteomics by Springer-Verlag New York Inc. (Hardback, 2006)
Brand newLOWEST PRICE
- AU $471.95+ AU $50.00 postage
- Brand new condition
- Sold by ausreseller
- See details for delivery est.
- AU $129.94+ AU $4.99 postage
- Good condition
- Sold by whattaplace
- See details for delivery est.
All listings for this product
Best-selling in Textbooks
Save on Textbooks
- AU $74.90Trending at AU $85.57
- AU $68.00Trending at AU $72.97
- AU $74.00Trending at AU $85.24
- AU $46.35Trending at AU $48.13
- AU $81.00Trending at AU $84.05
- AU $20.00Trending at AU $28.33
- AU $31.65Trending at AU $34.30
About this product
- DescriptionLess than twenty years ago photolithography and medicine were total strangers to one ather.Theyhadtyetmet,andtevenlookingeachotherupintheclassi?eds.And then,nucleicacidchips,micro?uidicsandmicroarraysenteredthescene,andrapidlythese strangersbecameindispensablepartnersinbiomedicine. Asrecentlyastenyearsagothetiofapplyingnatechlogytothe?ghtagainstd- easewasdominantlytheprovinceofthe?ctionwriters.Thoughtsofnaparticle-vehicled deliveryoftherapeuticalstodiseasedsiteswereanexerciseinscienti?csolitude,andgrounds for questioning one's ability to think like an established scientist . And today we have naparticulatepaclitaxelastheprimeoptionagainstmetastaticbreastcancer,proteomic pro?lingdiagstictoolsbasedontargetsurfacenatexturing,naparticlecontrastagents forallradiologicalmodalities,natechlogiesembeddedinhigh-distributionlaboratory equipment, and less than 152 vel namedical entities in the regulatory pipeline in theUSalone. Thisisatransformingimpact,byanymeasure,withclearevidenceoffurtheracceleration, supported by very vigorous investments by the public and private sectors throughout the world. Even joining the dots in a most conservative, linear fashion, it is easy to envision scenariosofpersonalizedmedicinesuchasthefollowing: patient-speci?cpreventionsupplantinggross,facelessinterventionstrategies; early detection protocols identifying signs of developing disease at the time when thediseaseismosteasilysubdued; personally tailored intervention strategies that are so routinely and inexpensively realized,thataccesstothemcanbesecuredbyeveryone; techlogiesallowingforlonglivesinthecompanyofdisease,asgoodneighbors, withoutimpairmentofthequalityoflifeitself. Thesevisionswillbecomereality.Thecontributionsfromtheworldsofsmall-scalete- logies are required to realize them. Invaluable progress towards them was recorded by the very scientists that have joined forces to accomplish the effort presented in this 4-volume collection. It has been a great privilege for me to be at their service, and at the service of the readership, in aiding with its assembly. May I take this oppor- nity to express my gratitude to all of the contributing Chapter Authors, for their - spired and thorough work. For many of them, writing about the history of their s- cialty?eldsofBioMEMSandBiomedicalNatechlogyhasreallybeenreportingabout their personal, individual adventures through scienti? c discovery and invation-a sort xxii FOREWORD of family album, with equations, diagrams, bibliographies and charts replacing Holiday pictures...
- Author BiographyDr. Mihri Ozkan is currently an Assistant Professor in the Department of Electrical Engineering at UC-Riverside with a research focus in nanotechnology and its applications in biology and engineering. She received her Ph.D. degree in the Department of Electrical and Computer Engineering at UC-San Diego and her M.S. degree in the Department of Materials Science and Engineering at Stanford University. She has over four years of industrial experience including at Applied Materials, Analog Devices and at IBM Almaden Research Center. Her awards and honors include Emerging Scholar Award of 2005 by the American Association of University Women, Invited participant of Kecks Future Initiative (2005) by the National Academy of Science, Regents Faculty Excellence Award (2001 and 2004), Visionary Science Award (2003), Technical Ingenuity Award (2003), Research Leadership Award (2003), Selected US team member in US-Japan Nanotechnology Symposium (2003), and Best graduate student awards from the Materials Research Society, the Society of Biomedical Engineering and Jacobs School of Engineering (1999, 2000, 2001). Dr. Ozkan's research is recognized as frontier research by the Virtual Journal of Nanoscale Science & Technology (edited by Dr. David Awschalom) and featured many times in public newspapers, on the cover of journals, online news sites and newsletters. She is an active board member and treasurer in the International Society for BioMEMS and Biomedical Nanotechnology. Her editorial activities include the Journal of Sensors and Actuators B and the Journal of Biomedical Microdevices. She holds more than 25 patent disclosures and about 8 US-patents. Professor Michael J. Heller began his position at University of California, San Diego in July 2001. He has a joint appointment between the departments of Bioengineering and Electrical and Computer Engineering (ECE). His experience (academic and industrial) includes many areas of biotechnology and biomedical instrumentation, with particular expertise in DNA synthesis, DNA microarray diagnostics and optoelectronic based biosensor technologies. Dr. Heller has been the co-founder of three high-tech companies: Nanogen, Nanotronics and Integrated DNA Technologies. Dr. Heller's most recent work involved the development of an integrated microelectronic array based system for genotyping, genetic and infectious disease diagnostics, protein analysis, cell separations and for nanofabrication applications. Dr. Heller has a respectable publication record, and has been an invited speaker to a large number of scientific conferences and meetings related to DNA microarrays, biosensors, lab-on-a-chip devices, bio-MEMS and nanotechnology. He has over 30 issued US patents related to microelectronic chips, microarrays and integrated devices for DNA hybridization, miniaturized sample to answer diagnostic devices, biosensors, genomics, proteomics, nanotechnology and nanofabrication, nano-based DNA optical storage and for fluorescent energy transfer in DNA nanostructures. Dr. Heller has been a panel member for the NAS(NAE) Review of National Nanotechnology Initiative 2001-2002; the NAS(NAE Engineer for the 2020 - 2001/2002; the White House (OSTP) National Nanotechnology Initiative 1999/2000; and has also been involved in a number of NSF Nanotechnology Workshops. Professor Mauro Ferrari is a pioneer in the fields of bioMEMS and biomedical nanotechnology. As a leading academic, a dedicated entrepreneur, and a vision setter for the Nation's premier Federal programs in nanomedicine, he brings a three-fold vantage perspective to his roles as Editor-in-Chief for this work. Dr. Ferrari has authored or co-authored over 150 scientific publications, 6 books, and over 20 US and International patents. Dr. Ferrari is also Editor-in-Chief of Biomedical Microdevices and series editor of the new Springer series on Emerging Biomedical Technologies. Several private sector companies originated from his la
- PublisherSpringer-Verlag New York Inc.
- Date of Publication02/11/2006
- SubjectTechnology: General & Reference
- Place of PublicationNew York, NY
- Country of PublicationUnited States
- ImprintSpringer-Verlag New York Inc.
- Content Note5 black & white tables, biography
- Weight1368 g
- Width178 mm
- Height254 mm
- Spine33 mm
- Volume editorMichael Heller,Mihrimah Ozkan
This item doesn't belong on this page.
Thanks, we'll look into this.